The mission of the food allergy center is to provide the best possible care through multidisciplinary care and research.
- Centers & Specialties
- Clinical Interests
- Food allergy
- Eosinophilic gastrointestinal disease
- Eczema (atopic dermatitis)
- Medical Education
- MD, PhD, New York University School of Medicine
- Residency, Montefiore Hospital & Medical Center
- Fellowship, Mount Sinai Hospital Medical Center
- Boston: Massachusetts General Hospital
- Patient Gateway
- Yes, learn more
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
Dr. Shreffler received his MD and PhD degrees from New York University and his Pediatrics training at the Albert Einstein College of Medicine. He completed his fellowship in Allergy & Immunology at the Mount Sinai School of Medicine in 2003. He is board certified in Pediatrics and Allergy/ Immunology and is a fellow of the American Academy of Allergy, Asthma and Immunology. He sits on the editorial board for the Journal of Allergy and Clinical Immunology, the leading specialty journal for his field.
- Research Summary
The Shreffler laboratory focuses on thecharacterization of cellular and humoral immune response to dietary antigensand the mechanisms of allergen-induced Th2 sensitization and oral tolerance.Areas of active investigation include 1) the mechanisms of allergenic dendriticcell (DC) activation by allergens and the DC signals that induce Th2differentiation; 2) the role of regulatory T cells in natural andimmunotherapy-induced oral tolerance; 3) the role of IgE diversity and basophilactivation and their regulation in both the effector response and in adaptiveimmune deviation in the context of food allergy and asthma. We primarily workwith human samples, often in conjunction with clinicalinterventional or observational studies, to interrogate both the innate andadaptive immune responses to major dietary and aeroallergens.
Working together with numerous collaboratorsincluding from the Consortium for Food AllergyResearch , the Inner City Asthma Consortium and our own newly established FoodAllergy Center at MGH, we are adapting the use of polychromatic flowcytometry, peptide microarray-based humoral immune profiling and systemsbiology approaches to uniquely characterize the phenotype and function of allergen-specificT and B cell responses and the regulations of effector cells in pediatric foodallergy and asthma.
Also important is the effort to understand whysome food proteins are potent allergens. In other words, what are themechanisms that influence early immune fate decisions to allergens and theintrinsic properties of those allergens that facilitate an allergic response. Weare studying this in human and murine model systems.
see PubMed link.
Shift the focus from holiday foods and plan memorable holiday activities for your children to enjoy this season that are safe and free from allergens.
Nine local mothers who blog about parenthood visited MassGeneral Hospital for Children (MGHfC) on July 31 to meet MGHfC physicians and learn about three popular pediatric health topics – obesity, food allergy and sleep behavioral disorders.
Wayne Shreffler, MD, PhD, division chief of Pediatric Allergy & Immunology at MassGeneral Hospital for Children and director of the Food Allergy Center at Massachusetts General Hospital, explains the differences between food challenges, which are established methods of care, and oral immunotherapy, which is still in research.
Food allergy is an immune-based disease affecting an estimated 5 percent of children younger than age 5 and 4 percent of teens and adults.
The Food Allergy Center is currently enrolling peanut allergic children ages 7–21 years in an oral immunotherapy (OIT) study, which involves administering small doses of peanut powder, increased over time. Read about Deb Edmunds' insiders experience with her daughter, Ashley Edmunds, who is currently enrolled.
The Food Allergy team at MassGeneral Hospital for Children answers common concerns about food allergies and school.
Wayne Shreffler, MD, PhD, a pediatric allergist at MassGeneral Hospital for Children and director of the Food Allergy Center at Massachusetts General Hospital, answers questions about proposed changes to air travel regulations.
Research presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology indicates that children may not outgrow milk allergies as early in life as experts had thought.
Read about three patients who have benefited from services at the Food Allergy Center.
With the hope of making a long-term impact in the field, The Food Allergy Center at Massachusetts General Hospital (MGH) and MassGeneral Hospital for Children (MGHfC) has been established to diagnose and treat known and suspected cases of food allergies.
Wayne Shreffler, MD, PhD, a pediatric allergist at MassGeneral Hospital for Children and director of the Food Allergy Center at Massachusetts General Hospital, answers questions about the diagnosis and treatment of food allergies.
In Fall 2009, Massachusetts General Hospital established a comprehensive center for the treatment and study of food allergy and food-related disorders to provide state-of-the-art care while investigating the mysteries that underlie these inadequately understood and as yet incurable diseases.
275 Cambridge Street
MGH Professional Office Building
Boston MA, 02114-3108